Skin/Recon/Abdomen Flashcards

1
Q

survival of pts w/ bile peritonitis? septic vs non septic?

A

nonsep = 100% survive
sep = 27% survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

risk factors for dvlpt of septic peritionitis after GI sx?

A

low TP, low alb, intraop hypotension, prep septic abd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

techniques to dec comps / deal w/ loss of domainn

A

organ removal
diaphragmatic advancement
mesh
fascial incisions
progressive pneumoperitoneum
staged reduction of congenital defects
leave linea open

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

4 alternative methods for closure of D hernia if 1’ repair not an option

A

mesh
omentum
liver
mm flap (lat, rectus, transversus)
fascia
diaphragmatic advancement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

diff in survival time for d-hernnia repair bw Boudreau 1987 and gibson 2005

A

boudreau –90% survival if sx w/in 1-3wks vs 60% survival w sx w/in 24hr
Gibson – 93% survival if sx w/in 24h of admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lu, JAVMA 2023. Evaluation of complications and long-term outcomes associated with 101 dogs and cats discharged with and without subcutaneous active closed-suction drains (2014–2022)

-when do they recc drain pull?
-risk of comps w/ pts discharged?

A

-dec incidence of seromas if drains removed at a production rate < 0.2 ml/kg/h

-complications: discharged w drain = 37% vs remove drain before dc = 4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Philip, JVECC 2022. Clinical and clinicopathological characteristics, treatment, and outcome for dogs and cats with confirmed FOXTAIL foreign body lesions: 791 cases (2009–2018)
- most common locations in cats vs dogs?
-aerobic or anaerobic most common?
-which empiric abx do they recc for foxtails?
-which abx do they say to avoid for foxtails?

A

-cats = ocular
-dogs = ear, skin/SQ, nose
-anaerobic > aerobic
-bacteriodies/fuso more common (anaerobic)
-empric reccs = chloramphenicol or clavamox
-AVOID amikacin, doxy, and enroflox (bc they have no anaerobic coverage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Jacques, JSAP 2022. Clinical, computed tomographic, surgical findings and outcome in dogs with sublumbar abscessation: 16 cases (2013‐2019)

-where were abscesses most common?
-recurrece rate?
-% of cases where material was found?

A
  • abscess in psoas m (100%), spondylitis (75%), vertebral osteomyelitis (38%), discospondylitis (13%). 67% had thoracic lesions
    -recurr in 14%
    -material found in 44%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stokes, JAVMA 2021. Comparison of bacteriologic culture results for skin wound swabs and skin wound biopsy specimens
-was culture or swab better?
-importance of negative result?
-agreement bw samples?

A

-swab is acceptable alternative to culture bx
-negative result obtained from culture of a swab is likely to be reliable
-Culture results agreed in 21.2% cases – but didn’t really change clinical tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Griffeuille, JAVMA 2021. Comparison of computed tomography and surgical findings and investigation of their associations with outcomes for dogs with sublumbar abscesses.
-recurrence ratee?
-what finding was significant assoc w recurrence?

A

-recurr = 25%
-diskospondylitis was significantly assoc w/ abscess recurrence (8x inc risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • Hamil, VS 2020. Pretreatment aerobic bacterial swab cultures to predict infection in acute open traumatic wounds: A prospective clinical study of 64 dog

-results of pretreatment/lavage swabs vs postlavage?
-conclusion?

A

o Fewer bacteria were cultured from postlavage than from prelavage swabs in 43 of 50 (86%) acute wounds

o Routine bacterial culturing of acute wounds is NOT helpful to predict infxn and doesn’t affect empiric abx selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Eiger, VS 2024. Use of near‐infrared fluorescence angiography with indocyanine green to evaluate direct cutaneous arteries used for canine axial pattern flaps

-did NIRF change plans?

A

o Sx more likely to adjust the landmark palpation caudal superficial epigastric APF margins based on fluorescence patterns & more likely to rely on landmarks if visualization score low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • Logothetou, VS 2023. Complications and influence of cutaneous closure technique on subdermal plexus flaps in 97 dogs (2006–2022)

-complication rate? diff bw skin closure vs staples?
-what was associated with w/ lower complications?

A

Complications= 53.6% – staples = 72% vs sutures =49% (unable to detect diff)

dec comps if– wound on head or used an advancement flap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • Forester, JSAP 2022. Outcome of caudal superficial epigastric axial pattern flaps in dogs and cats: 70 cases (2007‐2020)
  • cat vs dog complications?
    -most common complications?
A

o Dogs= 67%
o cats= 53%
o majority of complications = dehiscence > necrosis> seroma > edema&raquo_space;> infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • Villedieu, JSAP 2022. Outcome of superficial brachial axial pattern flaps used to close skin defects in dogs: 16 cases (1996‐2019)

-main conclusion?
-complication rate?
-revision sx?

A

o NOT for carpus; high complication rate

comps = 100%
1’ partial dehiscence (44%), partial flap necrosis ( 38%), seroma (31%)»
flap oedema (3/16, 19%) and complete flap necrosis (2/16, 13%)

revision sx = 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bonaventura, JAVMA 2021. Comparison of outcomes for single-session and delayed full-thickness applications of meshed skin grafts used to close skin defects after excision of tumors on the distal aspects of the limbs in dogs

-diff in graft survival for single session vs delayed grafting?
conclusion?

A

o No diff in % graft survival, graft outcome, complication rate

survival: SS = 90% vs delayed = 85%
o Shorter healing times / few bdg changes assoc/ w single session placement may be beneficial - either is ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Puerta, JSAP 2021. Superficial temporal axial pattern flap for facial reconstruction of skin defects in dogs and cats

-landmarks?
-recc max length?
-flap survival rate?

A

Landmarks: base = cd aspect of zygomatic arch caudally &lateral orbital rim rostrally

recc max length = mid dorsal orbital rim of contralateral eye
o 100% survival occurred in 90% of flaps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Jones, JAVMA 2019. Indications, complications, and outcomes associated with subdermal plexus skin flap procedures in dogs and cats: 92 cases (2000-2017).

-complication rate?
-most common Subdermal plexus flap?

A

o Complications = 51%
1’ minor

advancement flap used most commonly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Proot, JSAP 2019. Is the caudal auricular axial pattern flap robust? A multi‐centre cohort study of 16 dogs and 12 cats (2005 to 2016)

-more consistent wound healing in cats vs dogs?
-revision sx for cats vs dogs?
-most common comp?

A

o Optimal wound healing: dogs = 31% vs cats = 50%
o Revision sx: dogs = 50%, cats = 25%

most common comp = partial flap necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Billas, VS 2022. Incidence of and risk factors for surgical site infection following canine limb amputation

-what was associated with inc SSI?
-overall SSI rate?

A

o SSI = 12.5% for all (10.9% for clean procedures)
o ligasure increased odds of developing an SSI – electrosurgery +/- sharp transection did not

SSI: ligasure = 20% vs no ligasure = 9%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  • Agnoli, JSAP 2023. A retrospective study on bone metastasis in dogs with advanced‐stage solid cancer

-most common 1’ cancers metting to bone?
-most common histiotypes?
-MST w bone mets

A

o Most common 1’ tumors = mammary gland, spleen, tonsil
o Most common histotypes = carcinoma> HSA

MST = 30d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Nakano, JAVMA 2022. Outcome of appendicular or scapular osteosarcoma treated by limb amputation in cats
-distant met rate?
-OSA location that had worse px?
-MST?

A

distant mets = 40%
humeral OSA = worse px (inc rate of distant mets)
MST = 1.5yr (527d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Marconato, JAVMA 2021. Timing of adjuvant chemotherapy after limb amputation and effect on outcome in dogs with appendicular osteosarcoma without distant metastases

-what timing was found to be better for adjuvant chemotx after sx?

A

-early admin (w/in 5d) of surgery had improved survival times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Cherzan, VS 2023. Factors affecting prognosis in canine subcutaneous mast cell tumors: 45 cases

-MST for SQ MCT w lnn mets vs w/o lymph node mets?
-local recurrence ?

A

MST: mets = 551d (1.5y) vs no mets = 1722d (4.5 y)

Local recurrence=18%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
* Murphy, JAVMA 2023. Incidentally diagnosed mammary gland tumorsare less likely to be malignant than nonincidental mammary gland tumors -% benign for incidental MGT vs nonincidnetal ? -% malignant in nonincidental MGT
benign: incidental =93% vs nonincidental =70% malignant in nonincidental MGT = 30%
26
* Cockburn, JAVMA 2022. Marginal excision of cutaneous mast cell tumors in dogs was not associated with a higher rate of complications or prolonged wound healing than marginal excisionof soft tissue sarcomas -diff bw MCT vs STS healing comps? -what was associated with w complications?
complications: MCT =29% vs STS =31% (overall = ~30% bw groups) subdermal plexus flap reconstruction = inc risk for comps
27
* Evans, JAVMA 2021. Factors influencing complications following mastectomy procedures in dogs with mammary gland tumors: 140 cases (2009–2015) -what factors were assoc w complications? -complication rate?
factors assoc w comps: inc body size & prev spay; extensive mastectomy; no abx postop o Complication rate = 15%
28
* Villedieu, JAVMA 2021. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma. main conclusion? Diff in met rate bw grade 1/2 and grade 3 STS?
CXR = low yield for grade 1 or 2 STS or if mass present for <3mo mets: grade 3 = 38% vs grade 1/2 = 6%
29
* Chu, JAVMA 2020. Comparison of lateral surgical marginsof up to two centimeters with marginsof three centimeters for achieving tumor-free histologic margins following excisionof grade I or II cutaneous mast cell tumors in dogs -diff bw conservative vs wide margin approach? -main conclusion
clean margins: 2cm = 93% vs wide =92% (NSD) may be ok to use 2cm lateral margins for dogs w grade1 or 2 MCT
30
* Milovancev, VS 2020. Long‐term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2‐year‐long study -recurrence rate for dogs w low grade MCT vs STS? -margins used in this study?
recur: MCT =%, STS =0% (all 1' low grade MCT/STS) margins: MCT = 2cm, STS = 3cm 1 fascial plane for both
31
* worden, JAVMA 2023. Superficial anatomic landmarks can be used to triangulate the location of canine peripheral lymphocentrums: superficial cervical, axillary, and superficial inguinal -landmarks for superficial cervical? vs axillary? vs superficial inguinal?
 superficial cervical: wing of atlas, acromion process of scapula, greater tubercle of humerus  axillary: caudal border of transverse head of superficial pectoral muscle, caudal triceps muscle, ventral midline  superficial inguinal: origin of pectineus muscle, ipsilateral inguinal mammary gland, ventral midline
32
* Chalfon, JSAP 2022. Lymphadenectomy improves outcome in dogs with resected Kiupel high‐grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes -diff in MST for dogs w/ lnn extirpation vs w/o? -what was associated with w inc risk for recurrence? -what was lack of lymphadenecomty assoc w/?
MST: no lymphadenectomy = 250d (8mo) vs yes lymphadectomy = 371d (12mo) inc recurr w/ inc tumor size lack of lymphadenectomy was associated with higher risk of overall tumour progression, nodal progression, tumor related death
33
* Skinner, VS 2021. Metastasis to ipsilateral medial retropharyngeal and deep cervical lymph nodes in 22 dogs with THYROID CARCINOMA -main conclusion? -mets %?
o Metastases =45% o Deep cervical lymph nodes should be considered during imaging review of canine thyroid carcinoma and extirpation should be considered
34
* Ferrari, VS 2020. Biopsy of sentinel lymph nodes after injection of methylene blue and lymphoscintigraphic guidance in 30 dogs with mast cell tumors -correlation bw sentinal lnn and regionaal ln?
o Sentinel lymph nodes did not correspond to expected RLN in 63%
35
* Grimes, JAVMA 2019. Histologic evaluation of mandibular and medial retropharyngeal lymph nodes during staging of oral malignant melanoma and squamous cell carcinoma in dogs -ultimate tx recc? -how often was MRPLN affecteD? -reported met rate for OMM & oral SCC?
bx of only 1 Mand LN was insufficient to definitively r/o lymph node metastasis in dogs with OMM or OSCC --bilateral lymphadenectomy of the MLN and MRP LN recommended MRP LN affected in 80% dogs mets: OMM = 37% vs oral SCC = 29% (NSD, ~30% met rate)
36
* Walter, JAVMA 2024. Treatment of retroperitoneal sarcoma results in improved outcomes -most common histo dx? -surival time in this study vs Liptak 2004? -main conclusion?
HSA = 76% MST = 238d (8mo) -- longer than liptak 2004 (37d) greater survival time than prev thought, sx increases survival, adjuvant chemo may help
37
* Snipes, JAVMA 2023. Acute kidney injury is common in dogs with septic peritonitis and is associated with increased mortality. -% of dogs w/ AKI dx? risk factors for AKI? -of dogs not surviving, how many % had AKI? main conclusion
AKI = 40% (~20% preop & 20% postop) Significant factors for AKI = inc RR, Dec SBP, and inc BCS overall mortality = 20%-- AKI = 75% vs no AKI = 25% AKI common w septic abdomen and is associated with w/ dec survival
38
* Perry, JVECC 2022. Clinical features, outcome, and illness severity scoring in 32 dogs with urosepsis (2017–2018) -surival to discharge? common bacteria?
o 87.5% survived to discharge o Escherichia coli (37%) > Klebsiella pneumoniae (21.6%)> S pseudintermedius (16.2%)
39
* hornsey, JFMS 2022. Factors affecting survival todischarge in 53 cats diagnosed with uroabdomen: a single-centreretrospective analysis -% of cats suriving? what was associated with survival
survival = 75% (NSD bw med or sx mgmt) creatinine lvls assoc w survival
40
* Morgan et al, JAVMA 2019. Outcome after surgical and conservative treatments of canine peritoneopericardial diaphragmatic hernia: a mulitinstitutional study of 128 dogs -which dogs were more likely to be sx tx?
sx tx more likely if: younger, sexually intact, CS present, other congenital abN
41
* Rossanese et al. JAVMA 2023. Prevalence of malignancy and factors affecting outcome of cats undergoing splenectomy -% of cats w/ splenic neoplasia? -most common cancer? -MST longer for MCT or HSA? -what factors associated with HSA? -% of cats w spont hemoab dx w/ cancer?
neoplasia = 81% -- MCT 42%, HSA 40% 100% w/ spont hemoab = neoplasia MST: splenic MCT 1yr>> HSA 3mo factors assoc w HSA: anemia, splenic mass, spontaneous hemoabdomen
42
* Schick et al, JAVMA 2022. Evaluation of the validity of the double two-thirds rule for diagnosing hemangiosarcoma in dogs with nontraumatic hemoperitoneum due to a ruptured splenic mass: a systematic review -updated HSA odds?
If spleen- malignant 73% of time and 87% HSA 27.0% benign splenic lesion
43
* Burgess, JAVMA 2021. Development and validation of a multivariable model and onlinedecision-support calculator to aid in preoperative discriminationof benign from malignant splenic masses in dogs -factors associated with w splenic malignancy? (name 5)
 serum total protein concentration  presence (vs absence) of ≥ 2 nRBCs/100 WBCs  ultrasonographically assessed splenic mass diameter  number of liver nodules (0, 1, or ≥ 2)  presence (vs absence) of multiple splenic masses or nodules  moderate to marked splenic mass inhomogeneity  moderate to marked abdominal effusion  mesenteric, omental, or peritoneal nodules
44
* Millar et al, JAVMA 2021. Premature death in dogs with nontraumatic hemoabdomen and splenectomy with benign histopathologic findings -% of dogs w benign dz that died?
o 17% dogs with benign dz died w MST of 1-2mo (1/5 of dogs w benign splenic dz die quickly)
45
* Clarke, JSAP 2020. Clinical utility of liver biopsies in dogs undergoing splenectomy -conculsion? -incidental liver neoplasia on bx of grossly normal vs abN liver at time of splenectomy?
liver bx should be taken if liver appears grossly abnormal otherwise it is low yield if liver looks normal liver neoplasia: grossly normal = 2% vs abN = 30%
46
* Story et al, Vet Surg 2020. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma -MST for small vs large with sx+ chemo? -was ST diff?
MST: small breed =207d (7mo) vs large breed =139d (~5mo) (NSD) DFI was longer for small breeds
47
* Phipps et al, JAVMA 2020. Postoperative thrombocytosis and thromboelastographic evidence of hypercoagulability in dogs undergoing splenectomy for splenic masses -main findings?
hypercoagulability common during the first 2 weeks after splenectomy o hypercoagulability could inc the risk for development of postsplenectomy thrombotic conditions (portal system thrombosis, PTE)
48
3 techs for implanting mesh in abd herniorraphy? preferred?
-onlay - superficial to rectuss -inlay - mesh edge to fascia edgge -underlay/sublay- under rectus; preferred
49
autologous repair methods for abd hernia repair if cannot do 1’ body wall closure
VAC fascial releasing incisions abd wall partitioning muscular flaps (sartorial, rectus abd, ext abd obliqe)
50
structures to keep in mind for closure of inguinal hernias?
genitofemoral a/n/v ext pudendal a/v spermatic cord
51
5 complications of splenecotmy
hemorrhage vascular compromises arrhythmias SIRs/DIC/ARDS GDV inc risk for hemoparasite infxn loss of reservoir for rbcs
52
wendelburg 2016. survival of HSA w/ sx alone vs sx + chemo
sx alone = 1.6mo sx + chemo = 3-4.5mo
53
aronsohn 2009 -- found what % of dogs w spont hemoab had HSA? what % splenic?
63% HSA 74% spleen
54
which BV to ligate w splenecotmy
short ggastric L gastroepiploic splenic a/v after panc br
55
% of dogs w/ HSA that have dz in R atrium? dogs w R atrial mass have __ % of chance of splenic HSA vs dogs w/ 1' splenic HSA have __% chance of R atrial mass
25% dogs have R atrial mass if 1' R atrial - ~29% have spleen if 1' spleen -- 8% have R atrial
56
5 options to close palatal defect
buccal mucosal flaps angularis oris flap local flap from palate mucosa staged mandibular lip flap temporals mm flap sternohyoid/thyroid mm flap
57
5 prognostic factors associated with canine MCT
Ki-67 / c-kit mitotic index high grade or grade 3 tumor incomplete margins local/systemic CS at presentation tumors >3cm or quick growing lnn mets location -- prepuce/scrotal/perinall, subungal/nail, oral /Mm worse
58
4 options for sx excision of canine mammary GT? cats? species diff finn malignancy?
dogs - lumpectomy, simple mastectomy, regional mastectomy, chain mastectomy cats - chain mastectomy (bilateral) dogs = 50% malignancy; cats = 80% maligg
59
dog MGT dvlpt after spay?
before heat = 0.5%; before 2nnd heat = 8% > 2nd heat = 26%
60
2 /3 /4 rule for feline injection site sarcomas?
remove if: -> 2cm - lasts >3m -inc in size w/in 4 wks
61
3 ways to reconstruct lower eyelid
lip to lid 3rd eyelid advancement angularis oris APF
62
survival rate of split thicknesss grafts by Mckeever /braden et al?
87% survival for partial thickness vs 58% full thickness
63
4 steps in engraftement
advnacement plasmatic imbibition insoculation vascular inngrowth
64
3 rules for skin flap design / dvlpt
length of flap as long as length of wound avoid narrow flaps slt wider basse > width of flap should be long enough to cover defect relaxing incision parallel to wound
65
5 benefits of NPWT
dec edema remove bacteria enhance gran tissu dec bdg changes inc blood supply /perfusion inc wound fluid O2 inc flap survival dec pp CO2
66
3 spp diff bw cats/dogs w/ skin perfusion or wound strength or healing
dogs: greater density of collateral SQ vessels, heal via central pull of fibroblasts cats: smaller # BVs w wider distance; dec cutaneous percussion @ 1 wk; weaker wound strength @ 7d; healing via contraction along wound edges/peripheral; false healing
67
5 diff types of relaxing incisions / platies
mesh incisions bipedicle flap VY plasty Z plasty M plasty
68
prognostic factors for melanoma (skin tumors)
complete excision pigmented melanoma > amelanotic malignant features tumor location (oral cavity, MM, nails mostly malignant) lnn mets mitotic index
69
survival rate of APF
87-100%
70
angularis oris flap margins, uses
Flap base: labial commissure Dorsal: base to ventral zygomatic arch Ventral: base to ventral ramus Flap length: vertical ear canal use: palatal, facial, nasal
71
Superficial temporal flap margins, uses
Flap base: zygomatic arch Rostral: base  lateral orbital rim Caudal: base  rostral to ear Flap length: middle of contralateral dorsal orbital rim use: -maxillofacial -medial eyelid -palate
72
caudal auricular APF margins, uses
Flap base: depression bw wing of atlas + vertical ear canal Dorsal / ventral: parallel from base centered over lateral cervical Flap length: spine of scapula uses: -neck -facial -ear -dorsal head
73
Cervical cutaneous br of omocervical APF margins, uses
Caudal: acromion  scapular spine Cranial: parallel to caudal, equidistant to cranial scapula Flap length: variable, contralateral shoulder uses: -facial / ear -cervical -shoulder -axillary
74
thoracodorsal APF margins/uses
Cranial: acromion scapular spine Caudal: parallel to cranial, equidistant to caudal scapula Flap length: variable, contralateral shoulder uses: thoracic -shoulder -forelimb -axillary
75
superficial brachial APF margins/uses
Flap base: centered over dorsal 1/3 of flexor surf of elbow Lateral / medial: parallel from base, taper together Flap length: distal to greater tubercle uses: -antebrachial -elbow defects
76
dorsal deep circumflex APF marginsn/use
Flap base: CrV edge of wing of ilium Caudal: midway bw ilium / greater trochanter  dorsal Cranial: parallel to caudal, equidist to iliac wing Flap length: dorsal to contralateral flank use:-ipsilateral flank -lateral lumbar -lateromed thigh -greater trochanter
77
ventral deep circumflex iliac APF margins/usess
Flap base: CrV edge of wing of ilium Caudal: midway bw ilium / greater trochanter  ventral / Cr to femur Cranial: parallel to caudal Flap length: prox to patella uses-lateral abd wall -pelvis -sacrum
78
cranial superficial epigastric APF margins/uses
Flap base: Cd to thoracic cage Medial: abd midline Lateral: parallel to medial, epidistant to teats Flap length: includes glands 3-4 (+/- 5); end Cr to prepuce use -sternal defects
79
caudal superficial epigastric APF margins/uses
Medial: abd midline Lateral: parallel to medial, eipidstant to teats Flap length: may include glands 2-5 uses-caudal abd -flank / inguinal -preputial -perineal -thigh / stifle
80
lateral caudal APF margins/uses
Flap base: base of tail Incision: dorsal or ventral midline Flap length: variable, 3-4 Cd IV space uses-perineal -caudodorsal pelvic
81
genicular APF uses/margins
Flap base: 1cm prox to patella, 1.5cm distal to TT, laterally Dorsal / ventral: parallel to base, along femoral shaft Flap length: distal to greater trochanter usses-medial stifle -tibial defects
82
reverse saphenous conduit flap margins/use
Dorsal: central 1/3 of medial thigh @ patella; ligate saphenous a/v/n Cranial: 5-10mm cr to saphenous a/v Caudal: 5-10mm cd to saphenous a/v uses-distal PL
83
latisimuss dorsi myocutaneous flap uses/margins
Cranial: ventral acromion / triceps Caudal: 13th rib Ventral: skin fold, lower 1/3 humerus uses -thoracic wall -type V vascular pattern -dominant pedicle = thoracodorsal a
84
what flap is this
genicular APF
85
flap?
omocervical APF
86
flap?
thoracodorsal APF
87
flap
lateral thoracic APF
88
flap
superficial brachial APF
89
flap
cd superficial epigastric
90
flap
cr superficial epigastric
91
flap
dorsal deep circumflex APF
92
flap
caudal auricular APF
93
flap
superficial temporal APF
94
flap
lateral caudal APF
95
flap
auricularis oris APF
96
what was performed
transposition flap
97
what was performed
interpolation flap
98
removal (ml/kg/h or d) for SQ drain vs chest tube?
SQ drain = <0.2ml/kg/hr chest tube = <2ml/kg/d (0.1ml/kg/hr)
99
Emerson JSAP 2019: genicular APF for recon of skin defects in 22 dogs -flap survival? -recc uses?
survival = 99% good for small to medium sized skin defects of lateral/cranial crus
100
Liptak 2008. recon of chest wall defects after rib tumor resection -vascular pattern of latissimus doors? complications for autogenous vs composite vs prosthetic? recc to decc complications?
latissimus = type 5 vascular pattern (based on thoracodorsal a) complications: autogenous =10%, composite = 25%, mesh = 66% recc covering mesh with mm or omentum to dec complications
101
selmic JAVMA 2018. assoc of TPLO with proximal tibial OSA -risk of dvlping prox tibial OSA if hx TPLO vs no TPLO -what other factor was associated with inc risk for prox tibial OSA? -what was relevant regarding the TPLO / incidence of OSA historically?
hx of TPLO = 40x inc risk of prox tibial OSA inc body weight = inc risk (each kg inc in wt = 11% inc risk) hx related to use of early gen TPLO plates (made via casting , inc risk for corrosion)
102
alvarez-sanchez, VS 2023. comparisons of CT lymphangio and NIRF mapping for MCT -% of dogs with low grade/grade 2 MCT with mets? conclusions?
mets: 95% of dogs iodinated contrast lnn mapping and NRIF agreed ~80% of the time, recc combining both -- MCT mets may be more common with intermediate/low grade tumors
103
arz, JFMS 2023. lnn mets in feline low grade MCT % mets for low grade feline MCT?
mets =59% --> recc lymphadenectomy
104
iodence, JAVMa 2021. dogs undergoing sx excision of MCT are not at inc risk for incisional complications -% comps for MCT vs STS -what medication not associated with w inc risk of complications? -recc /advise for chemo use w MCT?
complications: MCT =13% vs STS =14% (no diff) steroid admin NOT associated with comps suggest caution w using <30d from sx if MCT
105
karma VS 2021. eval of scar revision after index primary excision of cutaneous MCT -% of dogs w MCT present in scar? -local recur after scar revision?
MCT @ scar revision site =14% local recurr = 4%
106
culp java 2010. spontaneous hemoabd in cats -% with neoplasia vs benign? -most common neoplasm? -most common organ of origin?
causes: benign =54% vs malignant = 46% (~50/50 for cats w hemoab) -HSA most common -spleen most common
107
clevland JAVMA 2016. incidence of malignancy and outcomes for dogs undergoing splenectomy for incidentally detected nonruptured splenic mass -% benign vs malignant
incidental splenic mass: benign = 70% vs malignant = 30%
108